← Back to Search

Bias Reduction Training for Rheumatic Diseases

N/A

Waitlist Available

Led By Candace H Feldman, MD, ScD

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months following the encounter of interest

Awards & highlights

Study Summary

This trial will test if a provider-based intervention can improve care for Black/African American and lower socioeconomic status patients with rheumatic diseases.

Who is the study for?

This trial is for English-speaking Black or African American adults, or those with low socioeconomic status indicated by Medicaid/Mass Health insurance. Participants must be diagnosed with SLE or inflammatory arthritis like RA, have visited the provider less than twice in the past year, and be able to consent. Rheumatologists participating need at least one clinical session per week.Check my eligibility

What is being tested?

The study tests an individuation intervention combined with implicit bias education aimed at improving rheumatic disease care quality for certain demographics. It also examines how this approach affects communication between providers and patients, treatment adherence, trust in providers, and satisfaction with care.See study design

What are the potential side effects?

Since this trial focuses on educational modules and behavioral interventions rather than medications, traditional physical side effects are not applicable. However, participants may experience discomfort discussing personal biases.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months following the encounter of interest

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months following the encounter of interest

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months following the encounter of interest for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of patients receiving high quality care

Secondary outcome measures

Adherence

Everyday Discrimination Scale

Implicit Association Test (IAT) scores

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm 1: Individuation Intervention plus implicit bias educationExperimental Treatment2 Interventions

10 rheumatologists who will have 10 patient interactions each (100 patients total) recorded Rheumatologists will watch implicit bias training modules and then will be instructed to incorporate an individuation strategy into each of their clinical encounters.

Group II: Arm 2: Implicit bias education onlyActive Control1 Intervention

10 rheumatologists randomized and stratified by hospital and gender

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,608 Previous Clinical Trials

11,469,692 Total Patients Enrolled

23 Trials studying Rheumatoid Arthritis

588,802 Patients Enrolled for Rheumatoid Arthritis

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,004,879 Total Patients Enrolled

5 Trials studying Rheumatoid Arthritis

256,485 Patients Enrolled for Rheumatoid Arthritis

Virginia Commonwealth UniversityOTHER

697 Previous Clinical Trials

22,884,811 Total Patients Enrolled

Media Library

Individuation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05116163 — N/A

Rheumatoid Arthritis Research Study Groups: Arm 1: Individuation Intervention plus implicit bias education, Arm 2: Implicit bias education only

Rheumatoid Arthritis Clinical Trial 2023: Individuation Intervention Highlights & Side Effects. Trial Name: NCT05116163 — N/A

Individuation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05116163 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants needed for this research?

"According to the records on clinicaltrials.gov, this trial is not presently enrolling participants. It was first posted on June 17th 2022 and edited most recently on September 27th 2022. However, there are still 323 separate trials actively recruiting patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology

Candace Hillary Feldman, MD 2022. "Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05116163.

All > Systemic Lupus Erythematosus > Ra